chartexchange

ALKS
Alkermes Inc. plc
stockNASDAQ

At CloseNov 19, 2026 3:59:58 PM EST
46.20USD-1.387%(-0.65)1,406,379
Pre-marketNov 19, 2026 9:13:30 AM EST
46.62USD-0.491%(-0.23)
After-hoursNov 19, 2026 4:00:30 PM EST
46.18USD-0.043%(-0.02)
Loading…
Loading…
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
Richard F. Pops
HQ
Dublin, Ireland
Previous Close
$46.85
Beta
0.81
52-Week High
$55.67 2026-07-07
52-Week Low
$27.00 2026-03-19
SMA 50
$43.71
SMA 200
$41.36
Avg. Vol 10D
1.48M
Avg. Vol 30D
1.71M
Avg. Vol 90D
1.82M
Relative Vol
0.82
168.04M
155.47M
19,647,994
0.2800%
2,200,000
445
May 15, 2000 · 2-for-1
ALKS Profile

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes' website at www.alkermes.com.

ALKS Performance
PeriodPriceDateChangeBeta
1W47.032026-11-13-1.76%2.125
1M44.112026-10-20+4.74%0.680
3M48.022026-08-20-3.79%0.709
6M36.982026-05-20+24.93%0.479
1Y28.192025-11-20+63.89%0.808
2Y27.912024-11-20+65.53%—
5Y23.242021-11-19+98.80%0.593
ALKS Stock Summary

Alkermes Inc. plc (NASDAQ:ALKS) stock price today is $46.20, and today's volume is 1,406,379. ALKS is down 1.387% today. The 30 day average volume is 1.71M. ALKS market cap is $7.76B with 168.04M shares outstanding.